Project Grant R34HL189015
Award Date 9/1/26
Completion Date 6/30/29
Dollars Obligated $271K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Glassboro, NJ 08028, USA
Similar Awards
- The National Heart, Lung, and Blood Institute awarded Duke University $136,646 under the Cardiovascular Diseases Research program (CFDA 93.837) on September 19, 2025, to conduct a K01 Career Development Award examining sex differences in barriers and predictors of physical activity participation during and following cardiac rehabilitation. The award is structured as a Project Grant with performance through August 31, 2030, at Duke University in Durham, North Carolina. The recipient will...
- The National Heart, Lung, and Blood Institute awarded Duke University $242,250 on June 18, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to conduct a secondary analysis identifying genetic predictors of physical activity intervention dropout and adherence. The project will analyze existing data from two completed physical activity interventions—the Heart Health Study and the HF-ACTION Trial—to identify genetic variants associated with intervention dropout and adherence...
- The National Heart, Lung, and Blood Institute awarded the Trustees of Indiana University $277,375 under the Cardiovascular Diseases Research program (CFDA 93.837) on July 25, 2026, to conduct a cluster randomized controlled trial assessing the feasibility and effect of Health Strides, a six-month, multi-level physical activity intervention targeting Head Start staff. The intervention combines workplace-level and individual-level components. The workplace component establishes a wellness...
- The National Heart, Lung, and Blood Institute awarded the University of North Carolina at Chapel Hill $222,309 on September 1, 2026, for secondary data analysis examining how community and peer-based interventions influence cardiovascular risk in diabetes management populations. The study conducts structural equation modeling across three major programs: 14 projects funded by the Robert Wood Johnson Foundation Diabetes Initiative, 14 evaluation and demonstration projects funded by Peers for...
- This $702,964 Project Grant award from the National Heart Lung and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports a research initiative titled "Facilitating Health System Implementation of Physical Activity Screening and Referral to Community-Based Programs: Exercise is Medicine Greenville." The project aims to examine the impact of implementation facilitation on improving the delivery and reach of the Exercise is Medicine Greenville program, which involves...
- The National Heart, Lung, and Blood Institute awarded $742,459 to Rutgers The State University of New Jersey, doing business as RBHS-School of Nursing, on August 15, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837). The recipient is conducting a comprehensive epidemiologic study evaluating treatment optimization among people with cystic fibrosis in the era of highly effective modulator therapy. The study leverages the Cystic Fibrosis Foundation Patient Registry linked to...
- The National Heart, Lung, and Blood Institute awarded Rutgers The State University of New Jersey $631,413 on August 1, 2026, as a Project Grant (R01HL183945) under the Cardiovascular Diseases Research program (CFDA 93.837). The award funds research investigating the role of lipotoxicity-induced splenic cell alternative splicing in obesity cardiomyopathy. The study examines how fatty acid-induced alternative splicing of the BCL2L1 gene in the spleen contributes to the development of obesity...
- This federal Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) provides $422,894 to Miami University to investigate the interactive effects of cardiorespiratory fitness and adiposity on the recovery of impaired glucose control and vascular function following a period of physical inactivity. The research aims to (1) examine how existing health status impacts the ability to recover impaired glucose control after reduced physical...
- The National Heart, Lung, and Blood Institute awarded The Regents of the University of Colorado (University of Colorado-Denver) $168,691 on August 1, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to refine, augment, and pilot test an affect-based physical activity promotion program for cancer survivors at elevated risk of cardiovascular disease. The award funds a K01 Career Development Award with a five-year period of performance through July 31, 2031. Work is...
- The National Heart, Lung, and Blood Institute awarded the University of Texas at Arlington $113,788 on August 14, 2026, under the Cardiovascular Diseases Research program (CFDA 93.837) to investigate how changes in shared public activity spaces—such as walking trails, parks, and sidewalks—affect long-term hypertension risk trajectories in aging adults. The research uses longitudinal data from the nationally representative Health and Retirement Study to identify physical activity-related pathways...